March 15, 2018

View Issues

Advanced Management of Opioid Overdose in the Emergency Department

This article aims to provide acute care providers with advanced techniques in the management of opioid overdoses, including the use of naloxone, the opioid receptor antagonist, as well as harm reduction management strategies aimed at long-term risk mitigation in this vulnerable population.

Read more

Issue Date: March 15, 2018

Financial Disclosure: Dr. Farel (CME question reviewer) owns stock in Johnson & Johnson. Dr. Quan (peer reviewer) serves on the speaker's bureau for BTG International and Pfizer. Dr. Wilkerson (author) has received research support from Roche, Novartis, Pfizer, Redhill Biopharm, Shire, Janssen Research & Development, Melinta Therapeutics, Prolong Pharmaceuticals, SNBL, and Teikoku. Dr. Schneider (editor), Dr. Stapczynski (editor), Ms. Light (nurse planner), Dr. Gatz (author), Dr. Liu (author), Ms. Mark (executive editor), Ms. Coplin (executive editor), and Ms. Hatcher (editorial group manager) report no financial relationships with companies related to the field of study covered by this CME activity.

Emergency Medicine Reports – March 15, 2018

March 15, 2018

Advanced Management of Opioid Overdose in the Emergency Department